Dark Genome Therapeutics Market, Share & Trends Analysis Report, By Indication (Cancer, Autoimmune diseases, Fibrotic diseases, Neurodegenerative Disorders), By Phases (Preclinical, Phase 1, Phase 2, Phase 3), By Region, and Segment Forecasts, 2025-2034